Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application

Abstract

Lung metastasis remains a leading cause of cancer mortality, driven not only by primary tumors but crucially by dynamic interactions within the premetastatic niche (PMN). Emerging evidence reveals that organ-specific PMN formation precedes tumor cell arrival, creating an immunosuppressive microenvironment conducive to metastatic colonization. Primary tumor-derived factors interact with lung resident cells, promoting the recruitment of bone marrow-derived cells and creating a favorable microenvironment for the migrating tumor cells. Despite progress, systematic integration of PMN's multilayered regulatory mechanisms—from mechanism to clinical application remains lacking. The review summarizes recent studies investigating the effects of PMN in the entire process of lung metastasis. Our discussion revolves primarily around extracellular vesicles, extracellular matrix remodeling, proinflammation, immunosuppression, angiogenesis, and metabolic reprogramming. We emphasize the impact of various treatment strategies for primary tumors on the PMN in clinical practice, while also summarizing current diagnostic methods and exploring new therapeutic possibilities in the PMN. Finally, we propose a roadmap for future investigations into the lung PMN, highlighting prioritized research axes that bridge mechanistic discoveries with bench-to-bedside translation of PMN-targeted interventions.

Keywords

clinical implication / lung metastasis / premetastatic niche / therapeutic strategy / tumor microenvironment

References

[1] D. Hanahan and R. A. Weinberg, “Hallmarks of Cancer: The next Generation,” Cell 144 (2011): 646-674.

[2] S. Gerstberger, Q. Jiang, and K. Ganesh, “Metastasis,” Cell 186 (2023): 1564-1579.

[3] K. E. De Visser and J. A. Joyce, “The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth,” Cancer Cell 41 (2023): 374-403.

[4] Z. Gong, Q. Li, J. Shi, et al., “Lung Fibroblasts Facilitate Pre-metastatic Niche Formation by Remodeling the Local Immune Microenvironment,” Immunity 55 (2022): 1483-1500. e9.

[5] Z. Huang, D. Bu, N. Yang, et al., “Integrated Analyses of Single-cell Transcriptomics Identify Metastasis-associated Myeloid Subpopulations in Breast Cancer Lung Metastasis,” Frontiers in Immunology 14 (2023): 1180402.

[6] S. M. Orbach, M. D. Brooks, Y. Zhang, et al., “Single-cell RNA-sequencing Identifies Anti-cancer Immune Phenotypes in the Early Lung Metastatic Niche During Breast Cancer,” Clinical & Experimental Metastasis 39 (2022): 865-881.

[7] Y.-C. Huang, C.-Y. Chang, Y.-Y. Wu, et al., “Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer,” Cancers 15 (2022): 176.

[8] I. Yofe, T. Shami, N. Cohen, et al., “Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary,” Cancer Discovery 13 (2023): 2610-2631.

[9] R. N. Kaplan, R. D. Riba, S. Zacharoulis, et al., “VEGFR1-positive Haematopoietic Bone Marrow Progenitors Initiate the Pre-metastatic Niche,” Nature 438 (2005): 820-827.

[10] I. J. Fidler, “The Pathogenesis of Cancer Metastasis: The ‘Seed and Soil’ hypothesis Revisited,” Nature Reviews Cancer 3 (2003): 453-458.

[11] S. García-Mulero, M. H. Alonso, J. Pardo, et al., “Lung Metastases Share Common Immune Features Regardless of Primary Tumor Origin,” Journal for ImmunoTherapy of Cancer 8 (2020): e000491.

[12] N. K. Altorki, G. J. Markowitz, D. Gao, et al., “The Lung Microenvironment: An Important Regulator of Tumour Growth and Metastasis,” Nature Reviews Cancer 19 (2019): 9-31.

[13] E. Madissoon, A. J. Oliver, V. Kleshchevnikov, et al., “A Spatially Resolved Atlas of the human Lung Characterizes a Gland-associated Immune Niche,” Nature Genetics 55 (2023): 66-77.

[14] J. M. Houthuijzen and K. E. de Visser, “The Lung Fibroblast as ‘Soil Fertilizer’ in Breast Cancer Metastasis,” Immunity 55 (2022): 1336-1339.

[15] Z. Wang, J. Zhu, Y. Liu, et al., “Tumor-polarized GPX3+ AT2 Lung Epithelial Cells Promote Premetastatic Niche Formation,” Proceedings of the National Academy of Science of the United States of America 119 (2022): e2201899119.

[16] S. K. Sharma, N. K. Chintala, S. K. Vadrevu, et al., “Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs,” Journal of immunology (Baltimore, Md.: 1950) 194 (2015): 5529-5538.

[17] E. D. Kramer, S. L. Tzetzo, S. H. Colligan, et al., “β-Catenin Signaling in Alveolar Macrophages Enhances Lung Metastasis Through a TNF-dependent Mechanism,” JCI Insight 8 (2023): e160978.

[18] S. Hiratsuka, A. Watanabe, H. Aburatani, et al., “Tumour-mediated Upregulation of Chemoattractants and Recruitment of Myeloid Cells Predetermines Lung Metastasis,” Nature Cell Biology 8 (2006): 1369-1375.

[19] L. Shen, H. Huang, Z. Wei, et al., “Integrated Transcriptomics, Proteomics, and Functional Analysis to Characterize the Tissue-specific Small Extracellular Vesicle Network of Breast Cancer,” MedComm 4 (2023): e433.

[20] Y. Ge, W. Mu, Q. Ba, et al., “Hepatocellular Carcinoma-derived Exosomes in Organotropic Metastasis, Recurrence and Early Diagnosis Application,” Cancer Letters 477 (2020): 41-48.

[21] L. Blavier, R. Nakata, P. Neviani, et al., “The Capture of Extracellular Vesicles Endogenously Released by Xenotransplanted Tumours Induces an Inflammatory Reaction in the Premetastatic Niche,” Journal of Extracellular Vesicles 12 (2023): e12326.

[22] A. Hoshino, B. Costa-Silva, T.-L. Shen, et al., “Tumour Exosome Integrins Determine Organotropic Metastasis,” Nature 527 (2015): 329-335.

[23] M. Yáñez-Mó, P. R.-M. Siljander, Z. Andreu, et al., “Biological Properties of Extracellular Vesicles and Their Physiological Functions,” Journal of Extracellular Vesicles 4 (2015): 27066.

[24] W. Jia, S. Liang, W. Lin, et al., “Hypoxia-induced Exosomes Facilitate Lung Pre-metastatic Niche Formation in Hepatocellular Carcinoma Through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB Pathway,” International Journal of Biological Sciences 19 (2023): 4744-4762.

[25] C. Du, X. Duan, X. Yao, et al., “Tumour-derived Exosomal miR-3473b Promotes Lung Tumour Cell Intrapulmonary Colonization by Activating the Nuclear Factor-κB of Local Fibroblasts,” Journal of Cellular and Molecular Medicine 24 (2020): 7802-7813.

[26] Z. Zeng, Y. Li, Y. Pan, et al., “Cancer-derived Exosomal miR-25-3p Promotes Pre-metastatic Niche Formation by Inducing Vascular Permeability and Angiogenesis,” Nature Communications 9 (2018): 5395.

[27] Y. Yan, C. Du, X. Duan, et al., “Inhibiting Collagen I Production and Tumor Cell Colonization in the Lung via miR-29a-3p Loading of Exosome-/Liposome-based Nanovesicles,” Acta Pharmaceutica Sinica B 12 (2022): 939-951.

[28] P. Gu, M. Sun, L. Li, et al., “Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis through Regulating CCL2 Expression in Lung Epithelial Cells,” Frontiers in Cell and Developmental Biology 9 (2021): 657158.

[29] T. Feng, P. Zhang, Y. Sun, et al., “High Throughput Sequencing Identifies Breast Cancer-secreted Exosomal LncRNAs Initiating Pulmonary Pre-metastatic Niche Formation,” Gene 710 (2019): 258-264.

[30] J. Xu, H. Wang, B. Shi, et al., “Exosomal MFI2-AS1 Sponge miR-107 Promotes Non-small Cell Lung Cancer Progression Through NFAT5,” Cancer cell international 23 (2023): 51.

[31] K. Domvri, S. Petanidis, D. Anestakis, et al., “Exosomal lncRNA PCAT-1 Promotes Kras-associated Chemoresistance via Immunosuppressive miR-182/miR-217 Signaling and p27/CDK6 Regulation,” Oncotarget 11 (2020): 2847-2862.

[32] Y. Liu, Y. Gu, Y. Han, et al., “Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils,” Cancer Cell 30 (2016): 243-256.

[33] X. Yin, M. Tian, J. Zhang, et al., “MiR-26b-5p in Small Extracellular Vesicles Derived From Dying Tumor Cells After Irradiation Enhances the Metastasis Promoting Microenvironment in Esophageal Squamous Cell Carcinoma,” Cancer Letters 541 (2022): 215746.

[34] Y. Takashima, M. Terada, M. Udono, et al., “Suppression of Lethal-7b and miR-125a/b Maturation by Lin28b Enables Maintenance of Stem Cell Properties in Hepatoblasts,” Hepatology (Baltimore, Md.) 64 (2016): 245-260.

[35] M. Qi, Y. Xia, Y. Wu, et al., “Lin28B-high Breast Cancer Cells Promote Immune Suppression in the Lung Pre-metastatic Niche via Exosomes and Support Cancer Progression,” Nature Communications 13 (2022): 897.

[36] L. Wu, Z. Yang, J. Zhang, et al., “Long Noncoding RNA HOTTIP Expression Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation,” Hepatobiliary Surgery and Nutrition 7 (2018): 429-439.

[37] I. Keklikoglou, C. Cianciaruso, E. Güç, et al., “Chemotherapy Elicits Pro-metastatic Extracellular Vesicles in Breast Cancer Models,” Nature Cell Biology 21 (2019): 190-202.

[38] L. Lobos-González, L. Oróstica, N. Díaz-Valdivia, et al., “Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models,” International Journal of Molecular Sciences 24 (2023): 16947.

[39] L. Zhong, D. Liao, J. Li, et al., “Rab22a-NeoF1 fusion Protein Promotes Osteosarcoma Lung Metastasis Through Its Secretion Into Exosomes,” Signal Transduction and Targeted Therapy 6 (2021): 59.

[40] Y. Wang, Y. Li, J. Zhong, et al., “Tumor-derived Cav-1 Promotes Pre-metastatic Niche Formation and Lung Metastasis in Breast Cancer,” Theranostics 13 (2023): 1684-1697.

[41] J. Lu, J. Li, S. Liu, et al., “Exosomal Tetraspanins Mediate Cancer Metastasis by Altering Host Microenvironment,” Oncotarget 8 (2017): 62803-62815.

[42] X. Mao, S. K. Tey, C. L. S. Yeung, et al., “Nidogen 1-Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1,” Advanced science (Weinheim, Baden-Württemberg, Germany) 7 (2020): 2002157.

[43] W.-W. Yang, L.-Q. Yang, F. Zhao, et al., “Epiregulin Promotes Lung Metastasis of Salivary Adenoid Cystic Carcinoma,” Theranostics 7 (2017): 3700-3714.

[44] S. Duan, S. Nordmeier, A. E. Byrnes, et al., “Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer,” International Journal of Molecular Sciences 22 (2021): 597.

[45] T. Frawley and O. Piskareva, “Extracellular Vesicle Dissemination of Epidermal Growth Factor Receptor and Ligands and Its Role in Cancer Progression,” Cancers 12 (2020): 3200.

[46] L. C. Zanetti-Domingues, S. E. Bonner, M. L. Martin-Fernandez, et al., “Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles,” Cells 9 (2020): 2505.

[47] E. Pavlakis, M. Neumann, and T. Stiewe, “Extracellular Vesicles: Messengers of p53 in Tumor-Stroma Communication and Cancer Metastasis,” International Journal of Molecular Sciences 21 (2020): 9648.

[48] E. Pavlakis and T. Stiewe, “p53's Extended Reach: The Mutant p53 Secretome,” Biomolecules 10 (2020): 307.

[49] M. Schuldner, B. Dörsam, O. Shatnyeva, et al., “Exosome-dependent Immune Surveillance at the Metastatic Niche Requires BAG6 and CBP/p300-dependent Acetylation of p53,” Theranostics 9 (2019): 6047-6062.

[50] I. Papiewska-Pająk, P. Przygodzka, D. Krzyżanowski, et al., “Snail Overexpression Alters the microRNA Content of Extracellular Vesicles Released From HT29 Colorectal Cancer Cells and Activates Pro-Inflammatory State in Vivo,” Cancers 13 (2021): 172.

[51] A. Ortiz, J. Gui, F. Zahedi, et al., “An Interferon-Driven Oxysterol-Based Defense Against Tumor-Derived Extracellular Vesicles,” Cancer Cell 35 (2019): 33-45.

[52] J. Gui, F. Zahedi, A. Ortiz, et al., “Activation of p38α Stress-activated Protein Kinase Drives the Formation of the Pre-metastatic Niche in the Lungs,” Nature Cancer 1 (2020): 603-619.

[53] C.-F. Wu, L. Andzinski, N. Kasnitz, et al., “The Lack of Type I Interferon Induces Neutrophil-mediated Pre-metastatic Niche Formation in the Mouse Lung,” International Journal of Cancer 137 (2015): 837-847.

[54] M. P. Plebanek, N. L. Angeloni, E. Vinokour, et al., “Pre-metastatic Cancer Exosomes Induce Immune Surveillance by Patrolling Monocytes at the Metastatic Niche,” Nature Communications 8 (2017): 1319.

[55] R. N. Hanna, C. Cekic, D. Sag, et al., “Patrolling Monocytes Control Tumor Metastasis to the Lung,” Science 350 (2015): 985-990.

[56] Y. Yao, R. Qian, H. Gao, et al., “LSD1 deficiency in Breast Cancer Cells Promotes the Formation of Pre-metastatic Niches,” npj Precision Oncology 8 (2024): 260.

[57] M. Akhtar, A. Haider, S. Rashid, et al., “Paget's ‘Seed and Soil’ Theory of Cancer Metastasis: An Idea whose Time Has Come,” Advances in Anatomic Pathology 26 (2019): 69-74.

[58] C. A. Hunter and S. A. Jones, “IL-6 as a Keystone Cytokine in Health and Disease,” Nature Immunology 16 (2015): 448-457.

[59] M. Werner-Klein, A. Grujovic, C. Irlbeck, et al., “Interleukin-6 Trans-signaling Is a Candidate Mechanism to Drive Progression of human DCCs During Clinical Latency,” Nature Communications 11 (2020): 4977.

[60] S. Rose-John, B. J. Jenkins, C. Garbers, et al., “Targeting IL-6 Trans-signalling: Past, Present and Future Prospects,” Nature Reviews Immunology 23 (2023): 666-681.

[61] J. Deng, Y. Liu, H. Lee, et al., “S1PR1-STAT3 signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites,” Cancer Cell 21 (2012): 642-654.

[62] D. E. Johnson, R. A. O'Keefe, and J. R. Grandis, “Targeting the IL-6/JAK/STAT3 Signalling Axis in Cancer,” Nature reviews Clinical oncology 15 (2018): 234-248.

[63] T. Wang and C. He, “TNF-α and IL-6: The Link Between Immune and Bone System,” Current Drug Targets 21 (2020): 213-227.

[64] E. H. Choy, F. De Benedetti, T. Takeuchi, et al., “Translating IL-6 Biology Into Effective Treatments,” Nature Reviews Rheumatology 16 (2020): 335-345.

[65] E. Lee, E. J. Fertig, K. Jin, et al., “Breast Cancer Cells Condition Lymphatic Endothelial Cells Within Pre-metastatic Niches to Promote Metastasis,” Nature Communications 5 (2014): 4715.

[66] J. W. Lee, M. L. Stone, P. M. Porrett, et al., “Hepatocytes Direct the Formation of a Pro-metastatic Niche in the Liver,” Nature 567 (2019): 249-252.

[67] S. A. Jones and B. J. Jenkins, “Recent Insights Into Targeting the IL-6 Cytokine family in Inflammatory Diseases and Cancer,” Nature Reviews Immunology 18 (2018): 773-789.

[68] C. Ieranò, C. D'Alterio, S. Giarra, et al., “CXCL12 loaded-dermal Filler Captures CXCR4 Expressing Melanoma Circulating Tumor Cells,” Cell Death & Disease 10 (2019): 562.

[69] N. Lavender, J. Yang, S.-C. Chen, et al., “The Yin/Yan of CCL2: A minor Role in Neutrophil Anti-tumor Activity in Vitro but a Major Role on the Outgrowth of Metastatic Breast Cancer Lesions in the Lung in Vivo,” BMC Cancer 17 (2017): 88.

[70] Y. Yang and Y. Cao, “The Impact of VEGF on Cancer Metastasis and Systemic Disease,” Seminars in Cancer Biology 86 (2022): 251-261.

[71] F. Balkwill, “TNF-alpha in Promotion and Progression of Cancer,” Cancer and Metastasis Reviews 25 (2006): 409-416.

[72] K. Yu, C. Yu, L. Jiao, et al., “The Function and Therapeutic Implications of TNF Signaling in MDSCs,” Biomolecules 12 (2022): 1627.

[73] H. Ji, R. Cao, Y. Yang, et al., “TNFR1 mediates TNF-α-induced Tumour Lymphangiogenesis and Metastasis by Modulating VEGF-C-VEGFR3 Signalling,” Nature Communications 5 (2014): 4944.

[74] A. Ghoshal, L. C. Rodrigues, C. P. Gowda, et al., “Extracellular Vesicle-dependent Effect of RNA-binding Protein IGF2BP1 on Melanoma Metastasis,” Oncogene 38 (2019): 4182-4196.

[75] A. Mazumdar, J. Urdinez, A. Boro, et al., “Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming,” International Journal of Molecular Sciences 21 (2020): 5451.

[76] R. Li, Y. Wang, X. Zhang, et al., “Exosome-mediated Secretion of LOXL4 Promotes Hepatocellular Carcinoma Cell Invasion and Metastasis,” Molecular cancer 18 (2019): 18.

[77] S. Wu, Q. Zheng, X. Xing, et al., “Matrix Stiffness-upregulated LOXL2 Promotes Fibronectin Production, MMP9 and CXCL12 Expression and BMDCs Recruitment to Assist Pre-metastatic Niche Formation,” Journal of Experimental & Clinical Cancer Research 37 (2018): 99.

[78] S. Wu, X. Xing, Y. Wang, et al., “The Pathological Significance of LOXL2 in Pre-metastatic Niche Formation of HCC and Its Related Molecular Mechanism,” European journal of cancer (Oxford, England: 1990) 147 (2021): 63-73.

[79] Y. Xiao, M. Cong, J. Li, et al., “Cathepsin C Promotes Breast Cancer Lung Metastasis by Modulating Neutrophil Infiltration and Neutrophil Extracellular Trap Formation,” Cancer Cell 39 (2021): 423-437. e7.

[80] Y. Liu and X. Cao, “Characteristics and Significance of the Pre-metastatic Niche,” Cancer Cell 30 (2016): 668-681.

[81] H. Peinado, H. Zhang, I. R. Matei, et al., “Pre-metastatic Niches: Organ-specific Homes for Metastases,” Nature Reviews Cancer 17 (2017): 302-317.

[82] Y. Maru, “The Lung Metastatic Niche,” Journal of Molecular Medicine (Berlin, Germany) 93 (2015): 1185-1192.

[83] M. Paolillo and S. Schinelli, “Extracellular Matrix Alterations in Metastatic Processes,” International Journal of Molecular Sciences 20 (2019): 4947.

[84] Y. Liu, D. Mao, H. Wang, et al., “Formation of Pre-metastatic Niches Induced by Tumor Extracellular Vesicles in Lung Metastasis,” Pharmacological Research 188 (2023): 106669.

[85] B. Wu, D.-A. Liu, L. Guan, et al., “Stiff Matrix Induces Exosome Secretion to Promote Tumour Growth,” Nature Cell Biology 25 (2023): 415-424.

[86] M. Liu, L. Xie, Y. Zhang, et al., “Inhibition of CEMIP Potentiates the Effect of Sorafenib on Metastatic Hepatocellular Carcinoma by Reducing the Stiffness of Lung Metastases,” Cell Death & Disease 14 (2023): 25.

[87] Y. N. Joo, H. Jin, S. Y. Eun, et al., “P2Y2R activation by Nucleotides Released From the Highly Metastatic Breast Cancer Cell MDA-MB-231 Contributes to Pre-metastatic Niche Formation by Mediating Lysyl Oxidase Secretion, Collagen Crosslinking, and Monocyte Recruitment,” Oncotarget 5 (2014): 9322-9334.

[88] J. T. Erler, K. L. Bennewith, T. R. Cox, et al., “Hypoxia-induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche,” Cancer Cell 15 (2009): 35-44.

[89] C. Rachman-Tzemah, S. Zaffryar-Eilot, M. Grossman, et al., “Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases,” Cell Reports 19 (2017): 774-784.

[90] J. Zhang, X. Han, H. Shi, et al., “Lung Resided Monocytic Myeloid-derived Suppressor Cells Contribute to Premetastatic Niche Formation by Enhancing MMP-9 Expression,” Molecular and Cellular Probes 50 (2020): 101498.

[91] H. Li, J. Li, Z. Bai, et al., “Collagen-induced DDR1 Upregulates CXCL5 to Promote Neutrophil Extracellular Traps Formation and Treg Infiltration in Breast Cancer,” International Immunopharmacology 120 (2023): 110235.

[92] J. S. Di Martino, A. R. Nobre, C. Mondal, et al., “A Tumor-derived Type III Collagen-rich ECM Niche Regulates Tumor Cell Dormancy,” Nature Cancer 3 (2022): 90-107.

[93] D. Gao, N. Joshi, H. Choi, et al., “Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition,” Cancer Research 72 (2012): 1384-1394.

[94] N. Cohen, D. Mundhe, S. K. Deasy, et al., “Breast Cancer-Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche,” Cancer Research 83 (2023): 3354-3367.

[95] S. Lin, L. Shu, Y. Guo, et al., “Cargo-eliminated Osteosarcoma-derived Small Extracellular Vesicles Mediating Competitive Cellular Uptake for Inhibiting Pulmonary Metastasis of Osteosarcoma,” Journal of Nanobiotechnology 22 (2024): 360.

[96] Y. Yui, J. Kumai, K. Watanabe, et al., “Lung Fibrosis Is a Novel Therapeutic Target to Suppress Lung Metastasis of Osteosarcoma,” International Journal of Cancer 151 (2022): 739-751.

[97] P. Xia, X. Ji, L. Yan, et al., “Roles of S100A8, S100A9 and S100A12 in Infection, Inflammation and Immunity,” Immunology 171 (2024): 365-376.

[98] Y. Chen, Y. Ouyang, Z. Li, et al., “S100A8 and S100A9 in Cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878 (2023): 188891.

[99] S. Hiratsuka, A. Watanabe, Y. Sakurai, et al., “The S100A8-serum Amyloid A3-TLR4 Paracrine Cascade Establishes a Pre-metastatic Phase,” Nature Cell Biology 10 (2008): 1349-1355.

[100] C. Zhang, Q. Li, Q. Xu, et al., “Pulmonary Interleukin 1 Beta/Serum Amyloid A3 Axis Promotes Lung Metastasis of Hepatocellular Carcinoma by Facilitating the Pre-metastatic Niche Formation,” Journal of Experimental & Clinical Cancer Research 42 (2023): 166.

[101] Y. H. Chung, J. Park, H. Cai, et al., “S100A9-Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy Against Metastatic Breast Cancer and Melanoma,” Advanced science (Weinheim, Baden-Württemberg, Germany) 8 (2021): e2101796.

[102] C. C. Hedrick and I. Malanchi, “Neutrophils in Cancer: Heterogeneous and Multifaceted,” Nature Reviews Immunology 22 (2022): 173-187.

[103] M. A. Giese, L. E. Hind, and A. Huttenlocher, “Neutrophil Plasticity in the Tumor Microenvironment,” Blood 133 (2019): 2159-2167.

[104] A. Tyagi, S. Sharma, K. Wu, et al., “Nicotine Promotes Breast Cancer Metastasis by Stimulating N2 Neutrophils and Generating Pre-metastatic Niche in Lung,” Nature Communications 12 (2021): 474.

[105] V. Papayannopoulos, “Neutrophil Extracellular Traps in Immunity and Disease,” Nature Reviews Immunology 18 (2018): 134-147.

[106] A. Mousset, E. Lecorgne, I. Bourget, et al., “Neutrophil Extracellular Traps Formed During Chemotherapy Confer Treatment Resistance via TGF-β Activation,” Cancer Cell 41 (2023): 757-775. e10.

[107] J. Albrengues, M. A. Shields, D. Ng, et al., “Neutrophil Extracellular Traps Produced During Inflammation Awaken Dormant Cancer Cells in Mice,” Science 361 (2018): eaao4227.

[108] J. Pan, L. Zhang, X. Wang, et al., “Chronic Stress Induces Pulmonary Epithelial Cells to Produce Acetylcholine That Remodels Lung Pre-metastatic Niche of Breast Cancer by Enhancing NETosis,” Journal of Experimental & Clinical Cancer Research 42 (2023): 255.

[109] Z. Zheng, Y.-N. Li, S. Jia, et al., “Lung Mesenchymal Stromal Cells Influenced by Th2 Cytokines Mobilize Neutrophils and Facilitate Metastasis by Producing Complement C3,” Nature Communications 12 (2021): 6202.

[110] Z. Zeng, S. Xu, F. Wang, et al., “HAO1-mediated Oxalate Metabolism Promotes Lung Pre-metastatic Niche Formation by Inducing Neutrophil Extracellular Traps,” Oncogene 41 (2022): 3719-3731.

[111] H. Garner and K. E. de Visser, “Immune Crosstalk in Cancer Progression and Metastatic Spread: A Complex Conversation,” Nature Reviews Immunology 20 (2020): 483-497.

[112] X. Li, P. Ramadori, D. Pfister, et al., “The Immunological and Metabolic Landscape in Primary and Metastatic Liver Cancer,” Nature Reviews Cancer 21 (2021): 541-557.

[113] J. Liu and X. Cao, “Glucose Metabolism of TAMs in Tumor Chemoresistance and Metastasis,” Trends in Cell Biology 33 (2023): 967-978.

[114] J. Kzhyshkowska, J. Shen, and I. Larionova, “Targeting of TAMs: Can We be More Clever Than Cancer Cells?,” Cellular & Molecular Immunology 21 (2024): 1376-1409.

[115] X. Xiang, J. Wang, D. Lu, et al., “Targeting Tumor-associated Macrophages to Synergize Tumor Immunotherapy,” Signal Transduction and Targeted Therapy 6 (2021): 75.

[116] D. G. DeNardo and B. Ruffell, “Macrophages as Regulators of Tumour Immunity and Immunotherapy,” Nature Reviews Immunology 19 (2019): 369-382.

[117] Y. Chen, J. Zhou, Z. Liu, et al., “Tumor Cell-induced Platelet Aggregation Accelerates Hematogenous Metastasis of Malignant Melanoma by Triggering Macrophage Recruitment,” Journal of Experimental & Clinical Cancer Research 42 (2023): 277.

[118] J.-H. Shi, L.-N. Liu, D.-D. Song, et al., “TRAF3/STAT6 axis Regulates Macrophage Polarization and Tumor Progression,” Cell Death and Differentiation 30 (2023): 2005-2016.

[119] X. Nie, L. Fu, Y. Cheng, et al., “Garcinone E Suppresses Breast Cancer Growth and Metastasis by Modulating Tumor-associated Macrophages Polarization via STAT6 Signaling,” Phytotherapy Research PTR 37 (2023): 4442-4456.

[120] M. Mei, L. Tang, H. Zhou, et al., “Honokiol Prevents Lung Metastasis of Triple-negative Breast Cancer by Regulating Polarization and Recruitment of Macrophages,” European Journal of Pharmacology 959 (2023): 176076.

[121] N. Du, H. Wan, H. Guo, et al., “Myeloid-derived Suppressor Cells as Important Factors and Potential Targets for Breast Cancer Progression,” Journal of Zhejiang University (Medical Sciences) 53 (2024): 785-795.

[122] Y.-C. Huang, M.-F. Hou, Y.-M. Tsai, et al., “Involvement of ACACA (acetyl-CoA carboxylase α) in the Lung Pre-metastatic Niche Formation in Breast Cancer by Senescence Phenotypic Conversion in Fibroblasts,” Cellular oncology (Dordrecht) 46 (2023): 643-660.

[123] Q. Lin, S. Zong, Y. Wang, et al., “Breast Cancer-derived CAV1 Promotes Lung Metastasis by Regulating Integrin α6β4 and the Recruitment and Polarization of Tumor-associated Neutrophils,” International Journal of Biological Sciences 20 (2024): 5695-5714.

[124] S.-Z. Xie, L.-Y. Yang, R. Wei, et al., “Targeting SPP1-orchestrated Neutrophil Extracellular Traps-dominant Pre-metastatic Niche Reduced HCC Lung Metastasis,” Experimental Hematology & Oncology 13 (2024): 111.

[125] L. Zhang, J. Pan, M. Wang, et al., “Chronic Stress-Induced and Tumor Derived SP1⁺ Exosomes Polarizing IL-1β⁺ Neutrophils to Increase Lung Metastasis of Breast Cancer,” Advancement of Science 12 (2025): 2310266.

[126] M. Eisenblaetter, F. Flores-Borja, J. J. Lee, et al., “Visualization of Tumor-Immune Interaction—Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment,” Theranostics 7 (2017): 2392-2401.

[127] Y. Guan, C. Gao, Y. Guo, et al., “The Effect and Mechanism of IL-37d on Neutrophil Recruitment in the Early Stage of Tumor Metastasis in the Lungs,” Discover Oncology 15 (2024): 728.

[128] H. Zheng, C. Yuan, J. Cai, et al., “Early Diagnosis of Breast Cancer Lung Metastasis by Nanoprobe-based Luminescence Imaging of the Pre-metastatic Niche,” J Nanobiotechnology 20 (2022): 134.

[129] Y.-A. Wang, X.-L. Li, Y.-Z. Mo, et al., “Effects of Tumor Metabolic Microenvironment on Regulatory T Cells,” Molecular cancer 17 (2018): 168.

[130] M. Wang, Z. Qin, J. Wan, et al., “Tumor-derived Exosomes Drive Pre-metastatic Niche Formation in Lung via Modulating CCL1+ Fibroblast and CCR8+ Treg Cell Interactions,” Cancer Immunology, Immunotherapy CII 71 (2022): 2717-2730.

[131] X. Jiang, J. Wang, L. Lin, et al., “Macrophages Promote Pre-metastatic Niche Formation of Breast Cancer Through Aryl Hydrocarbon Receptor Activity,” Signal Transduction and Targeted Therapy 9 (2024): 352.

[132] C. Li, K. Zhang, Z. Cheng, et al., “Neutrophil-targeted Liposomal Platform: A Shift in Novel Approach for Early Detection and Treatment of Cancer Metastasis,” Asian Journal of Pharmaceutical Sciences 19 (2024): 100949.

[133] H. G. Augustin and G. Y. Koh, “Organotypic Vasculature: From Descriptive Heterogeneity to Functional Pathophysiology,” Science 357 (2017): eaal2379.

[134] G. P. Gupta, D. X. Nguyen, A. C. Chiang, et al., “Mediators of Vascular Remodelling co-opted for Sequential Steps in Lung Metastasis,” Nature 446 (2007): 765-770.

[135] S. Liu, M. Jiang, Q. Zhao, et al., “Vascular Endothelial Growth Factor Plays a Critical Role in the Formation of the Pre-metastatic Niche via Prostaglandin E2,” Oncology Reports 32 (2014): 2477-2484.

[136] D. Meng, M. Meng, A. Luo, et al., “Effects of VEGFR1+ Hematopoietic Progenitor Cells on Pre-metastatic Niche Formation and in Vivo Metastasis of Breast Cancer Cells,” Journal of Cancer Research and Clinical Oncology 145 (2019): 411-427.

[137] J. Ma, L. Zhang, P. Yang, et al., “Integrated Analysis of Long Noncoding RNA Expression Profiles in Lymph Node Metastasis of Hepatocellular Carcinoma,” Gene 676 (2018): 47-55.

[138] X. Hu, J. Zhang, B. Xu, et al., “Multicenter Phase II Study of apatinib, a Novel VEGFR Inhibitor in Heavily Pretreated Patients With Metastatic Triple-negative Breast Cancer,” International Journal of Cancer 135 (2014): 1961-1969.

[139] X. W. Chen, T. J. Yu, J. Zhang, et al., “CYP4A in Tumor-associated Macrophages Promotes Pre-metastatic Niche Formation and Metastasis,” Oncogene 36 (2017): 5045-5057.

[140] D. Wang, F. Xiao, Z. Feng, et al., “Sunitinib Facilitates Metastatic Breast Cancer Spreading by Inducing Endothelial Cell Senescence,” Breast Cancer Research 22 (2020): 103.

[141] K. Yang, X. Wang, C. Song, et al., “The Role of Lipid Metabolic Reprogramming in Tumor Microenvironment,” Theranostics 13 (2023): 1774-1808.

[142] J. Wang, W. Zhang, C. Liu, et al., “Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer,” International Journal of Biological Sciences 20 (2024): 1884-1904.

[143] R. Bai, Y. Meng, and J. Cui, “Therapeutic Strategies Targeting Metabolic Characteristics of Cancer Cells,” Critical Reviews in Oncology/Hematology 187 (2023): 104037.

[144] H.-R. Jin, J. Wang, Z.-J. Wang, et al., “Lipid Metabolic Reprogramming in Tumor Microenvironment: From Mechanisms to Therapeutics,” Journal of Hematology & Oncology 16 (2023): 103.

[145] S. A. C. McDowell, S. Milette, S. Doré, et al., “Obesity Alters Monocyte Developmental Trajectories to Enhance Metastasis,” Journal of Experimental Medicine 220 (2023): e20220509.

[146] M. Qiu, K. Huang, Y. Liu, et al., “Modulation of Intestinal Microbiota by Glycyrrhizic Acid Prevents High-fat Diet-enhanced Pre-metastatic Niche Formation and Metastasis,” Mucosal Immunology 12 (2019): 945-957.

[147] A. M. Winkelkotte and A. Schulze, “Palmitate Paves the Way to Lung Metastasis,” Trends in cancer 9 (2023): 376-378.

[148] P. Altea-Manzano, G. Doglioni, Y. Liu, et al., “A Palmitate-rich Metastatic Niche Enables Metastasis Growth via p65 Acetylation Resulting in Pro-metastatic NF-κB Signaling,” Nature Cancer 4 (2023): 344-364.

[149] S. Ning, C. Liu, K. Wang, et al., “NUCB2/Nesfatin-1 Drives Breast Cancer Metastasis Through the Up-regulation of Cholesterol Synthesis via the mTORC1 Pathway,” Journal of Translational Medicine 21 (2023): 362.

[150] Z. Zhao, L. Zhong, K. He, et al., “Cholesterol Attenuated the Progression of DEN-induced Hepatocellular Carcinoma via Inhibiting SCAP Mediated Fatty Acid De Novo Synthesis,” Biochemical and Biophysical Research Communications 509 (2019): 855-861.

[151] Z. Gong, Q. Li, J. Shi, et al., “Immunosuppressive Reprogramming of Neutrophils by Lung Mesenchymal Cells Promotes Breast Cancer Metastasis,” Science Immunology 8 (2023): eadd5204.

[152] Z. Gong, Q. Li, J. Shi, et al., “Lipid-laden Lung Mesenchymal Cells Foster Breast Cancer Metastasis via Metabolic Reprogramming of Tumor Cells and Natural Killer Cells,” Cell Metabolism 34 (2022): 1960-1976. e9.

[153] P. Li, M. Lu, J. Shi, et al., “Lung Mesenchymal Cells Elicit Lipid Storage in Neutrophils That Fuel Breast Cancer Lung Metastasis,” Nature Immunology 21 (2020): 1444-1455.

[154] J. D. Schoenfeld and S. A. Vardhana, “Not so Neutral Lipids: Metabolic Regulation of the Pre-metastatic Niche,” Cell Metabolism 34 (2022): 1899-1900.

[155] M. A. Moresco, L. Raccosta, G. Corna, et al., “Enzymatic Inactivation of Oxysterols in Breast Tumor Cells Constraints Metastasis Formation by Reprogramming the Metastatic Lung Microenvironment,” Frontiers in Immunology 9 (2018): 2251.

[156] K. Kersten, R. You, S. Liang, et al., “Uptake of Tumor-derived Microparticles Induces Metabolic Reprogramming of Macrophages in the Early Metastatic Lung,” Cell Reports 42 (2023): 112582.

[157] T. Matsui, Y. Toda, H. Sato, et al., “Targeting Acidic Pre-metastatic Niche in Lungs by pH Low Insertion Peptide and Its Utility for Anti-metastatic Therapy,” Frontiers in Oncology 13 (2023): 1258442.

[158] G. Doglioni, J. Fernández-García, S. Igelmann, et al., “Aspartate Signalling Drives Lung Metastasis via Alternative Translation,” Nature 638 (2025): 244-250.

[159] S. M. Morrissey, F. Zhang, C. Ding, et al., “Tumor-derived Exosomes Drive Immunosuppressive Macrophages in a Pre-metastatic Niche Through Glycolytic Dominant Metabolic Reprogramming,” Cell Metabolism 33 (2021): 2040-2058. e10.

[160] M. Lv, B. Zhao, J. Zhang, et al., “ROS-responsive Core-shell Nano-inhibitor Impedes Pyruvate Metabolism for Reinforced Photodynamic Therapy and Interrupted Pre-metastatic Niche Formation,” Acta Biomaterialia 182 (2024): 288-300.

[161] F. Tang, Y. Tie, T.-X. Lan, et al., “Surgical Treatment of Osteosarcoma Induced Distant Pre-Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells,” Advanced science (Weinheim, Baden-Württemberg, Germany) 10 (2023): e2207518.

[162] L. Pang, O. W. H. Yeung, K. T. P. Ng, et al., “Postoperative Plasmacytoid Dendritic Cells Secrete IFNα to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence,” Cancer Research 82 (2022): 4206-4218.

[163] K. T.-P. Ng, L. Pang, J.-Q. Wang, et al., “Indications of Pro-inflammatory Cytokines in Laparoscopic and Open Liver Resection for Early-stage Hepatocellular Carcinoma,” Hepatobiliary & Pancreatic Diseases International HBPD INT (2023). S1499-3872(23)00180-7.

[164] M. Stöth, A. Freire Valls, M. Chen, et al., “Splenectomy Reduces Lung Metastases and Tumoral and Metastatic Niche Inflammation,” International Journal of Cancer 145 (2019): 2509-2520.

[165] F. Klemm and J. A. Joyce, “Microenvironmental Regulation of Therapeutic Response in Cancer,” Trends in Cell Biology 25 (2015): 198-213.

[166] M. Zhou, C. Luo, Z. Zhou, et al., “Improving Anti-PD-L1 Therapy in Triple Negative Breast Cancer by Polymer-enhanced Immunogenic Cell Death and CXCR4 Blockade,” Journal of Controlled Release Society 334 (2021): 248-262.

[167] Z. Zhang, Z. Yao, Z. Zhang, et al., “Local Radiotherapy for Murine Breast Cancer Increases Risk of Metastasis by Promoting the Recruitment of M-MDSCs in Lung,” Cancer cell International 23 (2023): 107.

[168] Q. Ye, S. Ling, S. Zheng, et al., “Liquid Biopsy in Hepatocellular Carcinoma: Circulating Tumor Cells and Circulating Tumor DNA,” Molecular Cancer 18 (2019): 114.

[169] X. Chen, J. Feng, W. Chen, et al., “Small Extracellular Vesicles: From Promoting Pre-metastatic Niche Formation to Therapeutic Strategies in Breast Cancer,” Cell Communication and Signaling 20 (2022): 141.

[170] J. Liu, L. Ren, S. Li, et al., “The Biology, Function, and Applications of Exosomes in Cancer,” Acta Pharmaceutica Sinica B 11 (2021): 2783-2797.

[171] M. Shen, K. Di, H. He, et al., “Progress in Exosome Associated Tumor Markers and Their Detection Methods,” Molecular Biomedicine 1 (2020): 3.

[172] J. Huang, C. Zhang, X. Wang, et al., “Near-Infrared Photodynamic Chemiluminescent Probes for Cancer Therapy and Metastasis Detection,” Angewandte Chemie (International ed in English) 62 (2023): e202303982.

[173] P. Lin, J. Shi, Y. Lin, et al., “Near-Infrared Persistent Luminescence Nanoprobe for Ultrasensitive Image-Guided Tumor Resection,” Advanced science (Weinheim, Baden-Württemberg, Germany) 10 (2023): e2207486.

[174] D. Han, X.-H. Ren, X.-R. Liao, et al., “A Multiple Targeting Nanoprobe for Identifying Cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells,” Nano Letters 23 (2023): 3678-3686.

[175] C. Deng, M. Zheng, J. Xin, et al., “A Nanoparticle Composed of Totally Hospital-available Drugs and Isotope for Fluorescence/SPECT Dual-modal Imaging-guided Photothermal Therapy to Inhibit Tumor Metastasis,” Journal of Colloid & Interface Science 651 (2023): 384-393.

[176] M. Xiang, C. Chen, Y. Chen, et al., “Unexpected Inhibitory Role of Silica Nanoparticles on Lung Cancer Development by Promoting M1 Polarization of Macrophages,” International Journal of Nanomedicine 19 (2024): 11087-11104.

[177] L. Pisanu, K. Mucaj, V. Conio, et al., “Lung Bronchiectasisas a Paradigm of the Interplay Between Infection and Colonization on Plastic Modulation of the Pre-metastatic Niche,” Frontiers in Oncology 14 (2024): 1480777.

[178] W. Mu, P. Gu, H. Li, et al., “Exposure of Benzo[a]Pyrene Induces HCC Exosome-circular RNA to Activate Lung Fibroblasts and Trigger Organotropic Metastasis,” Cancer Communications 44 (2024): 718-738.

[179] L. Bejarano, M. J. C. Jordāo, and J. A. Joyce, “Therapeutic Targeting of the Tumor Microenvironment,” Cancer Discovery 11 (2021): 933-959.

[180] Z. Lu, L. Ma, L. Mei, et al., “Micellar Nanoparticles Inhibit the Postoperative Inflammation, Recurrence and Pulmonary Metastasis of 4T1 Breast Cancer by Blocking NF-κB Pathway and Promoting MDSCs Depletion,” International Journal of Pharmaceutics 628 (2022): 122303.

[181] Z. Lu, H. Liu, L. Ma, et al., “Micellar Nanoparticles Inhibit Breast Cancer and Pulmonary Metastasis by Modulating the Recruitment and Depletion of Myeloid-derived Suppressor Cells,” Nanoscale 14 (2022): 17315-17330.

[182] Y. Zhou, P. Ke, X. Bao, et al., “Peptide Nano-blanket Impedes Fibroblasts Activation and Subsequent Formation of Pre-metastatic Niche,” Nature Communications 13 (2022): 2906.

[183] C. Xia, W. Bai, T. Deng, et al., “Sponge-Like Nano-system Suppresses Tumor Recurrence and Metastasis by Restraining Myeloid-derived Suppressor Cells-mediated Immunosuppression and Formation of Pre-metastatic Niche,” Acta Biomaterialia 158 (2023): 708-724.

[184] L. Zhao, C. Gu, Y. Gan, et al., “Exosome-mediated siRNA Delivery to Suppress Postoperative Breast Cancer Metastasis,” Journal of Controlled Release 318 (2020): 1-15.

[185] J. Li, P. Zhang, M. Zhou, et al., “Trauma-Responsive Scaffold Synchronizing Oncolysis Immunization and Inflammation Alleviation for Post-Operative Suppression of Cancer Metastasis,” ACS Nano 16 (2022): 6064-6079.

[186] Y. Tang, Y. Lu, Y. Chen, et al., “Pre-metastatic Niche Triggers SDF-1/CXCR4 Axis and Promotes Organ Colonisation by Hepatocellular Circulating Tumour Cells via Downregulation of Prrx1,” Journal of Experimental & Clinical Cancer Research 38 (2019): 473.

[187] X. Zhang and F.-G. Wu, “Intratumorally Delivering Cytokines via a Universal and Modular Strategy,” Molecular Biomedicine 4 (2023): 5.

[188] Y. Zheng, Z. Lu, J. Ding, et al., “Therapeutic Adenovirus Vaccine Combined Immunization With IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma,” Cancers 14 (2022): 4512.

[189] S. Kaczanowska, D. W. Beury, V. Gopalan, et al., “Genetically Engineered Myeloid Cells Rebalance the Core Immune Suppression Program in Metastasis,” Cell 184 (2021): 2033-2052.

[190] B. He, A. Johansson-Percival, J. Backhouse, et al., “Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy,” Cell Reports 30 (2020): 714-724. e5.

[191] C. Chen, R. Huang, J. Zhou, et al., “Formation of Pre-metastatic Bone Niche in Prostate Cancer and Regulation of Traditional chinese Medicine,” Frontiers in Pharmacology 13 (2022): 897942.

[192] Y. Zhang, X. Wang, Y. Mou, et al., “Traditional Chinese Medicine in the Treatment of Lung Pre-metastatic Niche: Efficacies and Mechanisms,” Heliyon 10 (2024): e38431.

[193] X. Zhu, X. Zhang, J. Shen, et al., “Gut Microbiota-dependent Modulation of Pre-metastatic Niches by Jianpi Yangzheng Decoction in the Prevention of Lung Metastasis of Gastric Cancer,” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 128 (2024): 155413.

[194] J. Li, B. Shi, X. Ren, et al., “Lung-intestinal Axis, Shuangshen Granules Attenuate Lung Metastasis by Regulating the Intestinal Microbiota and Related Metabolites,” Phytomedicine 132 (2024): 155831.

[195] Chinese Journal of Cancer. The 150 Most Important Questions in Cancer Research and Clinical Oncology Series: Questions 6-14: Edited by Chinese Journal of Cancer. Chinese Journal of Cancer 2017; 36: 33, s40880-017-0200-0.

[196] J. Qu, F. S. Kalyani, L. Liu, et al., “Tumor Organoids: Synergistic Applications, Current Challenges, and Future Prospects in Cancer Therapy,” Cancer communications (London, England) 41 (2021): 1331-1353.

[197] W. Liu, J. Song, X. Du, et al., “AKR1B10 (Aldo-keto reductase family 1 B10) promotes Brain Metastasis of Lung Cancer Cells in a Multi-organ Microfluidic Chip Model,” Acta Biomaterialia 91 (2019): 195-208.

[198] C. S. McGinnis, Z. Miao, D. Superville, et al., “The Temporal Progression of Lung Immune Remodeling During Breast Cancer Metastasis,” Cancer Cell 42 (2024): 1018-1031.

[199] Y. Qi, X. Cui, M. Han, et al., “Radiomics Analysis of Lung CT Image for the Early Detection of Metastases in Patients With Breast Cancer: Preliminary Findings From a Retrospective Cohort Study,” European Radiology 30 (2020): 4545-4556.

[200] R. Li, Y. Qi, M. Han, et al., “Computed Tomography Reveals Microenvironment Changes in Premetastatic Lung,” European Radiology 31 (2021): 4340-4349.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.